eicosapentaenoic acid ethyl ester has been researched along with Dermatitis, Atopic in 1 studies
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, M | 1 |
| Ohyanagi, C | 1 |
| Kawaguchi, N | 1 |
| Matsuda, H | 1 |
| Miyamoto, Y | 1 |
| Ohya, S | 1 |
| Nabe, T | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Dermatitis, Atopic
| Article | Year |
|---|---|
Eicosapentaenoic acid ethyl ester ameliorates atopic dermatitis-like symptoms in special diet-fed hairless mice, partly by restoring covalently bound ceramides in the stratum corneum.
Topics: Administration, Oral; Animals; Biological Availability; Ceramides; Dermatitis, Atopic; Diet; Disease | 2018 |